Pages

Wednesday, July 13, 2022

 "After Roe, Autoimmune Patients Lose Access to "Gold-Standard" Treatment

Patients with rheumatic illnesses may lose access to methotrexate, a cheap drug prescribed to millions of Americans each year, since the Supreme Court overturned Roe v. Wade, according to an investigation by the Los Angeles Times."


quoting Med Page Today, July 13, 2022

No comments:

Post a Comment